References

• 2011The productivity crisis in pharmaceutical R&D918 cited
• 2010The importance of new companies for drug discovery: origins of a decade of new drugs344 cited
• 2008Drug discovery: new models for industry–academic partnerships141 cited
• 2012Mergers and innovation in the pharmaceutical industry114 cited
• 2014Racing to define pharmaceutical R&D external innovation models65 cited
• 2016Public- and Private-Sector Contributions to the Research and Development of the Most Transformational Drugs in the Past 25 Years: From Theory to Therapy63 cited
• 2014Industry-University Collaborations in Canada, Japan, the UK and USA – With Emphasis on Publication Freedom and Managing the Intellectual Property Lock-Up Problem51 cited
• 2012Towards a European Strategy for Medicines Research (2014–2020): The EUFEPS Position Paper on Horizon 202038 cited
• 2014Academic drug discovery centres: the economic and organisational sustainability of an emerging model25 cited
• 2012Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergisticlingua franca15 cited
• 2014Universities seek to boost industry partnerships10 cited

Cited by

No citing works inside the corpus for this window.